Psychometric analysis of the Korean version of the high-dose chemotherapy specific quality of life questionnaire module from the European Organization for Research and Treatment of Cancer (EORTC QLQ-HDC29)
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Kyung Im | - |
dc.contributor.author | Kim, Jae Hyun | - |
dc.contributor.author | Ji, Eun Hee | - |
dc.contributor.author | Jang, Jun Ho | - |
dc.contributor.author | Kim, Jin Seok | - |
dc.contributor.author | Kwon, Ji-Hyun | - |
dc.contributor.author | Kim, Inho | - |
dc.contributor.author | Park, Seonyang | - |
dc.contributor.author | Velikova, Galina | - |
dc.contributor.author | Yoon, Sung-Soo | - |
dc.contributor.author | Oh, Jung Mi | - |
dc.date.accessioned | 2021-09-04T00:53:12Z | - |
dc.date.available | 2021-09-04T00:53:12Z | - |
dc.date.created | 2021-06-17 | - |
dc.date.issued | 2016-04 | - |
dc.identifier.issn | 0962-9343 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/88982 | - |
dc.description.abstract | We evaluated the psychometric properties of the Korean version of the European Organization for Research and Treatment of Cancer high-dose chemotherapy specific quality of life questionnaire module (EORTC QLQ-HDC29) when implemented with Korean patients by conducting a multicenter, longitudinal study in three Korean hospitals. A total of 226 patients who scheduled to receive the HDC followed by hematopoietic stem cell transplantation (HSCT) were enrolled. The patients were asked to complete three questionnaires [the EORTC Core Questionnaire (QLQ-C30), QLQ-HDC29, and the Functional Assessment of Cancer Therapy-Bone Marrow Transplantation] at four points in time: before HSCT and 100, 180, and 365 days after HSCT. Standard validity and reliability analyses were performed. Internal consistency of the QLQ-HDC29 was generally acceptable, as tested by Cronbach's alpha, except for the scales body image and the inpatient issues. Cronbach's alpha values for the Korean version of the QLQ-HDC29 were almost in accordance with results of the original version, except for the scales body image (lower to the original QLQ-HDC29, alpha = 0.73) and impact on family (higher to the original QLQ-HDC29, alpha = 0.52). Known-group comparison analyses showed significantly higher symptom burdens in patients with poor performance status or graft versus host disease (similar to the original QLQ-HDC29). The QLQ-HDC29 indicated good convergent and discriminant validity and showed responsiveness to changes in line with a clinical course over time after HSCT. The QLQ-HDC29 is generally reliable and adequate to assess QoL in Korean patients undergoing HDC followed by HSCT. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | SPRINGER | - |
dc.subject | BONE-MARROW-TRANSPLANTATION | - |
dc.subject | STEM-CELL TRANSPLANTATION | - |
dc.subject | RECOVERY | - |
dc.subject | LEUKEMIA | - |
dc.subject | QLQ-C30 | - |
dc.subject | IMPACT | - |
dc.title | Psychometric analysis of the Korean version of the high-dose chemotherapy specific quality of life questionnaire module from the European Organization for Research and Treatment of Cancer (EORTC QLQ-HDC29) | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Kim, Kyung Im | - |
dc.identifier.doi | 10.1007/s11136-015-1121-5 | - |
dc.identifier.scopusid | 2-s2.0-84940845614 | - |
dc.identifier.wosid | 000374300200011 | - |
dc.identifier.bibliographicCitation | QUALITY OF LIFE RESEARCH, v.25, no.4, pp.881 - 890 | - |
dc.relation.isPartOf | QUALITY OF LIFE RESEARCH | - |
dc.citation.title | QUALITY OF LIFE RESEARCH | - |
dc.citation.volume | 25 | - |
dc.citation.number | 4 | - |
dc.citation.startPage | 881 | - |
dc.citation.endPage | 890 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | ssci | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Health Care Sciences & Services | - |
dc.relation.journalResearchArea | Public, Environmental & Occupational Health | - |
dc.relation.journalWebOfScienceCategory | Health Care Sciences & Services | - |
dc.relation.journalWebOfScienceCategory | Health Policy & Services | - |
dc.relation.journalWebOfScienceCategory | Public, Environmental & Occupational Health | - |
dc.subject.keywordPlus | BONE-MARROW-TRANSPLANTATION | - |
dc.subject.keywordPlus | STEM-CELL TRANSPLANTATION | - |
dc.subject.keywordPlus | RECOVERY | - |
dc.subject.keywordPlus | LEUKEMIA | - |
dc.subject.keywordPlus | QLQ-C30 | - |
dc.subject.keywordPlus | IMPACT | - |
dc.subject.keywordAuthor | Hematopoietic stem cell transplantation | - |
dc.subject.keywordAuthor | High-dose chemotherapy | - |
dc.subject.keywordAuthor | QLQ-HDC29 | - |
dc.subject.keywordAuthor | Quality of life | - |
dc.subject.keywordAuthor | Validation | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
145 Anam-ro, Seongbuk-gu, Seoul, 02841, Korea+82-2-3290-2963
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.